Pepaxto is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Oncopeptides, Ab. The primary component is Melphalan Flufenamide.
Product ID | 73657-020_779bf257-f198-4c8e-8ddf-87d3c14d8c77 |
NDC | 73657-020 |
Product Type | Human Prescription Drug |
Proprietary Name | Pepaxto |
Generic Name | Melphalan Flufenamide |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2021-02-26 |
Marketing Category | NDA / |
Application Number | NDA214383 |
Labeler Name | Oncopeptides, AB |
Substance Name | MELPHALAN FLUFENAMIDE |
Active Ingredient Strength | 20 mg/50mL |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2021-02-26 |
NDC Exclude Flag | N |
Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
PEPAXTO 79275014 not registered Live/Pending |
Oncopeptides AB 2019-11-05 |